Allogene Therapeutics ALLO Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Allogene Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The official record: Allogene Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Allogene Therapeutics's preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Allogene Therapeutics's preferred stock, shares authorized?
- Allogene Therapeutics (ALLO) reported preferred stock, shares authorized of $10M in Q1 2026.
- How has Allogene Therapeutics's preferred stock, shares authorized changed year-over-year?
- Allogene Therapeutics's preferred stock, shares authorized decreased by 0.0% year-over-year, from $10M to $10M.
- What is the long-term trend for Allogene Therapeutics's preferred stock, shares authorized?
- Over 5 years (2020 to 2025), Allogene Therapeutics's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $10M to $10M.